Oncolytic Virus Immunotherapy

Oncolytic Virus Immunotherapy exemplifies an exciting cancer treatment which stimulates a patient-specific immune response against cancer by making use of a virus’ ability to replicate and kill tumor tissue selectively. Immune- stimulating chemicals are produced by genetically modifying the Oncolytic Viruses which also makes them more specific for cancer cells. Therapeutic cancer vaccines and mAb therapy are some of the cancer immunotherapies with which Oncolytic virus immunotherapy are often combined. 

  • Engineering Oncolytic viruses
  • Oncolytic behavior of wild-type viruses
  • Tumor cell phenotype
  • Inherent tumor physiology

Are you interested in

Mail us at

Program Enquiry
vaccines@alliedconference.com
Sponsorship/Exhibitor/Advertising
sponsoraac@alliedacademies.com
General Query
vaccines@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy


Copyright © 2018-2019 Allied Academies, All Rights Reserved.